Allspring Global Investments
ZVRA icon

Allspring Global Investments’s Zevra Therapeutics ZVRA Stock Holding History

Allspring Global Investments’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Buy
+216,866
New +$2.41M ﹤0.01% 998
2023
Q4 		– Sell
-4,706
Closed -$22.7K – 2782
2023
Q3 		$22.7K Buy
+4,706
New +$23.5K ﹤0.01% 2482
2022
Q2 		– Sell
-48
Closed – – 2964
2022
Q1 		$0 Buy
+48
New +$305 ﹤0.01% 3076

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allspring Global Investments's ZVRA Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 216,866 shares worth $2.99M. The stake represents ﹤0.01% of the portfolio and ranks #998 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in ZVRA as recently as Q3 2023.

Allspring Global Investments first reported a position in ZVRA in Q1 2022 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Allspring Global Investments held 216,866 shares of Zevra Therapeutics worth $2.99M as of Q2 2026.
  • Zevra Therapeutics was a new Allspring Global Investments position in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #998 holding.
  • Allspring Global Investments first reported a position in Zevra Therapeutics in Q1 2022 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.